[1] Twort F W.An investigation on the nature of ultra-microscopic viruses[J].Lancet,1915,186(4):1241-1243.[2] d'Herelle F.On an invisible microbe antagonistic to dysentery bacilli[J].Comptes Rendus Acad Des Sci,1917,165(3):373-375.[3] Maura D,Debarbieux L.Bacteriophages as twenty-first century antibacterial tools for food and medicine[J].Appl Microbiol Biotechnol,2011,90(3):851-859.[4] Brussow H,Kutter E.Bacteriophages:Biology and applications[M].Florid:CRC Press,2005.[5] Ackermann H W.Frequency of morphological phage descriptions in the year 2000[J].Archives of Virology,2001,146:843-857.[6] Lenski R E.Dynamics of interactions between bacteria and virulent bacteriophage[J].Adv Microb Ecol,1988,10:1-44.[7] Chatterjee S,Rothenberg E.Interaction of bacteriophage Ⅰ with itsE.coli receptor,Lam B[J].Viruses,2012,4(11):3162-3178.[8] 李 灏.畜禽肠道致病菌及其噬菌体的分离及特性研究[D].济南:山东大学,2002.[9] 司樨东.噬菌体学[M].北京:科学出版社,1996.[10] Phillippa C,Ian C.Natural Campylobacter control with bacteriophage[J].World Poultry,2006,26(6):25-26.[11] Smith H W,Huggins M B.Experimental infection of calves,piglets and lambs with mixtures of invasive and enteropathogenic strains of Escherichia coli[J].Med Microbiol,1979,12(4):507-510.[12] Smith H W,Huggins M B.Successful treatment of experimentalEscherichia coli infections in mice using phage:Its general superiority over antibiotics[J].Gen Microbiol,1982,128(2):307-318.[13] Smith H W,Huggins M B.Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves,piglets and lambs[J].Gen Microbiol,1983,129(8):2659-2675.[14] Abedon S T,Kuhl S J,Blasdel B G,et al.Phage treatment of human infections[J].Bacteriophage,2011,1(2):66-85.[15] Tanji Y,Shimada T,Fukudomi H,et al.Therapeutic use of phage cocktail for controlling Escherichia coli O157∶H7 in gastrointestinal tract of mice[J].Biosci Bioeng,2005,100(3):280-287.[16] Tanji Y,Shimada T,Yoichi M,et al.Toward rational control of Escherichia coli O157∶H7 by a phage cocktail[J].Appl Microbiol Biotechnol,2004,64(2):270-274.[17] Sheng H,Knecht H J,Kudva I T,et al.Application of bacteriophages to control intestinal Escherichia coli O157∶H7 levels in ruminants[J].Appl Environ Microbiol,2006,72(8):5359-5366.[18] Atterbury R J,Van Bergen M A P,Ortiz F,et al.Bacteriophage therapy to reduce salmonella colonization of broiler chickens[J].Appl Environ Microbiol,2007,73(14):4543-4549.[19] Capparelli R,Parlato M,Borriello G,et al.Experimental phage therapy against Staphylococcus aureus in mice[J].Antimicrob Agents Chemother,2007,51(8):2765-2773.[20] Morello E,Saussereau E,Maura D,et al.Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains:First steps towards treatment and prevention[J].PLoS One,2011,6(2):e16963.[21] Karumidze N,Kusradze I,Rigvava S,et al.Isolation and characterization of lytic bacteriophages of Klebsiella oxytoca[J].Curr Microbiol,2013,66(3):251-258.[22] Birendra R,Tiwari K,Shukho K,et al.Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models[J].Microbiology,2011,49(6):994-999.[23] Tang F,Li Y Z,Zhang W,et al.Complete genome sequence of T4-like Escherichia coli bacteriophage HX01[J].J Virol,2012,86(24):13871.[24] Golshahi L,Lynch K H,Dennis J J,et al.In vitro delivery of bacteriophages KS4-M and ΦKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis[J].J Appl Microbiol,2011,110(1):106-117.[25] Fu W,Forster T,Mayr O,et al.Bacteriophage cocktail for the prevention of biofilm formation by Pseudomanas aeruginosa on catheters in an in vitro model system[J].Antimicrob Agents Chemother,2010,54(1):397-404.[26] Bokyung S,Jiae Y,Jeong L,et al.Characterization of LysB4,an endolysin from the Bacillus cereus-infecting bacteriophage B4[J].BMC Microbiology,2012,12(15):33.[27] Nariya H,Miyata S,Tamai E,et al.Identification and characterization of a putative endolysin encoded by episomal phage phiSM101 ofClostridium perfringens[J].Appl Microbiol Biotechnol,2011,90(6):1973-1979.[28] Burrowes B,Harper D R,Anderson J,et al.Bacteriophage therapy:Potential usesin the control of antibiotic-resistant pathogens[J].Expert Rev Anti Infec Ther,2011,9(9):775-785.[29] Harper D R,Morales S.Bacteriophage therapy:Practicability and clinical need meet in the multidrug-resistance era[J].Future Microbiol,2012,7(7):797-799.[30] Loc-Carrillo C,Abedon S T.Pros and cons of phage therapy[J].Bacteriophage,2011,1(2):111-114.[31] Carlton R M,Noordman W H,Biswas B,et al.Bacteriophage P100 for control of Listeria monocytogenes in foods:Genome sequence,bioinformatic analyses,oral toxicity study,and application[J].Regul Toxicol Pharmacol,2005,43(3):301-312.[32] Fischetti V A.Novel method to control pathogenic bacteria on human mucous membranes[J].Ann NY Acad Sci,2003,987:207-214.[33] Borysowski J,Weber-Dabrowska B,Gorski A.Bacteriophage endolysins as a novel class of antibacterial agents[J].Exp Biol Med (Maywood),2006,231(4):366-377.[34] Eyer L,Pantucek R,Zdrahal Z,et al.Structural protein analysis of the polyvalent Staphylococcal bacteriophage 812[J].Proteomics,2006,7(1):64-72.[35] Croft A C,D'Antoni A V,Terzulli S L.Update on the anti-bacterial resistance crisis[J].Med Sci Monit,2007,13(6):103-118.[36] Grisaru-Soen G,Sweed Y,Lerner-Geva L,et al.Nosocomial bloodstream infections in a pediatric intensive careunit:3-year survey[J].Med Sci Monit,2007,13(6):251-257.[37] Zhou Z,Guan R,Yang Y,et al.Identification of New Delhi metallo-β-lactamase gene (NDM-1) from a clinical isolate ofAcinetobacter junii in China[J].Can J Microbiol,2012,58(1):112-115.[38] Pouillot F,Chomton M,Blois H,et al.Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b∶H4-ST131 Escherichia coli strain producing CTX-M-15[J].Antimicrob Agents Chemother,2012,56(7):3568-3575.[39] Birendra R,Tiwari K,Shukho K,et al.Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models[J].Microbiology,2011,49(6):994-999. |